Cargando…

Proof-of-concept in vivo evaluation of targeted therapeutics: lessons from immunoliposomes

Detalles Bibliográficos
Autor principal:	Benz, CC
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300145/ http://dx.doi.org/10.1186/bcr684

Ejemplares similares

Therapeutic targets for rheumatoid arthritis: lessons from animal models
por: Iwakura, Yoichiro, et al.
Publicado: (2012)

Docetaxel–trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer
por: Rodallec, Anne, et al.
Publicado: (2018)

Is a cure for HIV feasible? A proof-of-concept in humanized mice
por: Speck, Roberto
Publicado: (2013)

MR-Augmented Cardiopulmonary Exercise Testing- a proof of concept in Sickle Cell Disease (SCD)
por: Ako, Emmanuel O, et al.
Publicado: (2016)

Diffuse myocardial fibrosis - a therapeutic target? Proof of regression at 1-year following aortic valve replacement: the RELIEF-AS study
por: Treibel, Thomas A, et al.
Publicado: (2016)

O025 Smart polymer implants as an emerging technology for treating airway collapse in obstructive sleep apnea: proof of concept
por: Sideris, A, et al.
Publicado: (2021)

Canakinumab treatment in patients with active recurrent or chronic TNF-receptor associated syndrome (TRAPS): Efficacy and safety results from a proof of concept study
por: Lachmann, H, et al.
Publicado: (2015)

Volumetric MR-guided high-intensity focused ultrasound with direct skin cooling for the treatment of symptomatic uterine fibroids: proof of concept study
por: Ikink, Marlijne, et al.
Publicado: (2015)

O027 A randomised dose finding study of combination dronabinol and acetazolamide for the treatment of obstructive sleep apnoea: A proof of concept study
por: Walsh, J, et al.
Publicado: (2022)

Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo.
por: Vingerhoeds, M. H., et al.
Publicado: (1996)

Targeting immunoliposomes to EGFR-positive glioblastoma
por: Kasenda, B., et al.
Publicado: (2022)

Development of a SMCs model from HGPS-iPS and proofs of principle
por: Ferreira, Lino
Publicado: (2015)

Evaluation of Targeted Delivery to the Brain Using Magnetic Immunoliposomes and Magnetic Force
por: Thomsen, Louiza Bohn, et al.
Publicado: (2019)

Scale-up of community action for health: lessons from a realistic evaluation of the Mitanin program in Chhattisgarh, India
por: Nambiar, Devaki, et al.
Publicado: (2012)

Impact of RSBY on enrolled households: lessons from Gujarat
por: Seshadri, Tanya, et al.
Publicado: (2012)

HIFU immunotherapy: lessons from animal to clinical studies
por: Wu, Feng
Publicado: (2015)

Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine
por: Noble, Charles O., et al.
Publicado: (2009)

Tax as a therapeutic target in ATL
por: Dassouki, Zeina, et al.
Publicado: (2015)

Antimalarial activity of ulein and proof of its action on the Plasmodium falciparum digestive vacuole
por: de Oliveira, Alaíde Braga, et al.
Publicado: (2010)

Immunoliposomes doubly targeted to transferrin receptor and to α-synuclein
por: Loureiro, Joana A, et al.
Publicado: (2015)

Angiogenesis and arthritis: a potential therapeutic target?
por: Grosjean, J, et al.
Publicado: (2004)

74 Lessons from the COVID-19 Pandemic for Food Supply Chains
por: Anderson, John D, et al.
Publicado: (2021)

A RNAi-based therapeutic proof of concept targets salmonid whirling disease in vivo
por: Sarker, Subhodeep, et al.
Publicado: (2017)

Interleukin-6 as a therapeutic target in locomotor disorders
por: Nishimoto, Norihiro, et al.
Publicado: (2012)

Telomerase: a breast cancer chemopreventive and therapeutic target
por: Shay, JW
Publicado: (2000)

Targeting the glycans of the HIV envelope as a therapeutic tool
por: Balzarini, Jan
Publicado: (2011)

Cytomics of the tumour microenvironment: therapeutic targeting (keynote lecture)
por: Smith, Paul
Publicado: (2015)

Adjustable gravitational valves. From the conception in 1996 to first implantations 2008
por: Aschoff, Alfred, et al.
Publicado: (2009)

Engaging students with clickers in language lessons
por: Cheung, Janet, Man-wai, et al.
Publicado: (2014)

Recruitment and retention of health professionals in the European Union: lessons from country experiences
por: Dussault, Gilles
Publicado: (2014)

10 The Impact of Global Disasters on Our Pets: Lessons from COVID-19
por: Protopopova, Alexandra
Publicado: (2021)

Lessons from TP53 mutations in breast cancers: from carcinogen fingerprints to clinical correlates
por: Hainaut, P, et al.
Publicado: (2000)

MiR-126-Loaded Immunoliposomes against Vascular Endothelial Inflammation In Vitro and Vivo Evaluation
por: Tang, Yongyu, et al.
Publicado: (2023)

Compliance comparison of different bracing concepts
por: Selle, Andreas, et al.
Publicado: (2010)

S4.5b A randomized, double blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surgery, in patients with eumycetoma in Sudan—pharmacokinetic results
por: Brüggemann, Roger, et al.
Publicado: (2022)

The emerging role of HHV-6 in neurologic disease: lesson from multiple sclerosis and epilepsy
por: Jacobson, Steven
Publicado: (2006)

Child growth trajectories to adult disease: lessons from UK birth cohort studies
por: Ong, Ken K
Publicado: (2015)

S4.5a A randomized, double blind phase II proof-of-concept superiority trial of fosravuconazole 200 mg or 300 mg weekly dose versus itraconazole 400 mg daily, all three arms in combination with surgery, in patients with eumycetoma in Sudan—top line results
por: Fahal, Ahmed Hassan, et al.
Publicado: (2022)

Envisioning new targets and new approaches for molecular-based cancer therapeutics
por: Tainer, JA
Publicado: (2005)

Targeting KIT on innate immune cells enhances the antitumor activity of checkpoint inhibitors in vivo
por: Gedrich, Richard, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ks03if5toe4n6c5mnp5lhhib1l